Cite
HARVARD Citation
Arzu Yaşar, H. et al. (2020). Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. Journal of oncology pharmacy practice. pp. 267-272. [Online].